Christopher Rivera
Director/Board Member at HAPBEE TECHNOLOGIES, INC.
Profile
Christopher Eugene Rivera was the founder of Hyperion Therapeutics, Inc. (founded in 2006) where he served as the Chief Executive Officer from 2006 to 2015.
He is currently the Chairman, President & Chief Executive Officer at EMulate Therapeutics, Inc. (since 2014), Director at Otonexus Medical Technologies, Inc. (since 2023), Director at Hapbee Technologies, Inc. (since 2019), and Director at CV6 Therapeutics (NI) Ltd.
(since 2018).
In his former positions, he was the President & Chief Executive Officer at Washington Biotechnology & Biomedical Association, Principal at Centocor, Inc., Principal at Cephalon, Inc., and Senior Vice President-Commercial Operations at Tercica, Inc. (from 2005 to 2006).
Mr. Rivera obtained an undergraduate degree from Northwestern Oklahoma State University and a graduate degree from the University of Oklahoma.
Christopher Rivera active positions
| Companies | Position | Start |
|---|---|---|
| HAPBEE TECHNOLOGIES, INC. | Director/Board Member | 2022-02-15 |
EMulate Therapeutics, Inc.
 EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Chief Executive Officer | 2015-12-31 |
CV6 Therapeutics (NI) Ltd.
 CV6 Therapeutics (NI) Ltd. Pharmaceuticals: MajorHealth Technology CV6 Therapeutics (NI) Ltd. develops and manufactures pharmaceutical drugs. The company is based in Belfast, UK. The British company was founded in 2013 by Robert D. Ladner, Karl A. Mulligan. Robert D. Ladner has been the CEO since 2013. | Director/Board Member | 2017-12-31 |
Otonexus Medical Technologies, Inc.
 Otonexus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Otonexus Medical Technologies, Inc. is a holding company engages in health care industry. The firm designs, develops, and commercializes an ultrasound medical device that diagnoses middle ear infections in children and adults. The company was founded by Gerge A. Gates and Mark A. Moehring and is headquartered in Seattle, WA. | Director/Board Member | 2023-04-04 |
Former positions of Christopher Rivera
| Companies | Position | End |
|---|---|---|
| HYPERION THERAPEUTICS INC | Chief Executive Officer | 2014-12-31 |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Chief Operating Officer | 2006-07-31 |
| Washington Biotechnology & Biomedical Association | Chief Executive Officer | - |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | - |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Corporate Officer/Principal | - |
Training of Christopher Rivera
| Northwestern Oklahoma State University | Undergraduate Degree |
| University of Oklahoma | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HAPBEE TECHNOLOGIES, INC. | Electronic Technology |
| Private companies | 8 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
Otonexus Medical Technologies, Inc.
Otonexus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Otonexus Medical Technologies, Inc. is a holding company engages in health care industry. The firm designs, develops, and commercializes an ultrasound medical device that diagnoses middle ear infections in children and adults. The company was founded by Gerge A. Gates and Mark A. Moehring and is headquartered in Seattle, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association | |
CV6 Therapeutics (NI) Ltd.
CV6 Therapeutics (NI) Ltd. Pharmaceuticals: MajorHealth Technology CV6 Therapeutics (NI) Ltd. develops and manufactures pharmaceutical drugs. The company is based in Belfast, UK. The British company was founded in 2013 by Robert D. Ladner, Karl A. Mulligan. Robert D. Ladner has been the CEO since 2013. | Health Technology |
- Stock Market
- Insiders
- Christopher Rivera
